174 related articles for article (PubMed ID: 17105361)
1. Review: clinical transfusion management in sickle cell disease.
Rogers ZR
Immunohematology; 2006; 22(3):126-31. PubMed ID: 17105361
[No Abstract] [Full Text] [Related]
2. Transfusion management in sickle cell disease.
Wanko SO; Telen MJ
Hematol Oncol Clin North Am; 2005 Oct; 19(5):803-26, v-vi. PubMed ID: 16214645
[TBL] [Abstract][Full Text] [Related]
3. Optimal Manual Exchange Transfusion Protocol for Sickle Cell Disease: A Retrospective Comparison of Two Comprehensive Care Centers in the United Kingdom and Canada.
Mian HS; Ward R; Telfer P; Kaya B; Kuo KH
Hemoglobin; 2015; 39(5):310-5. PubMed ID: 26114740
[TBL] [Abstract][Full Text] [Related]
4. Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.
Hoppe C; Neumayr L
Hematol Oncol Clin North Am; 2019 Jun; 33(3):355-371. PubMed ID: 31030807
[TBL] [Abstract][Full Text] [Related]
5. Isovolemic hemodilution-red cell exchange for prevention of cerebrovascular accident in sickle cell anemia: the standard operating procedure.
Matevosyan K; Anderson C; Sarode R
J Clin Apher; 2012; 27(2):88-92. PubMed ID: 22302664
[TBL] [Abstract][Full Text] [Related]
6. The chiasm: transfusion practice versus patient blood management.
Spahn DR; Shander A; Hofmann A
Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):37-42. PubMed ID: 23590914
[TBL] [Abstract][Full Text] [Related]
7. Atrial septal defect closure on cardiopulmonary bypass in a sickle cell anemia: role of hydroxyurea and partial exchange transfusion.
Gosavi KS; Dash SK; Shah BN; Upasani CB
Ann Card Anaesth; 2010; 13(2):145-7. PubMed ID: 20442545
[TBL] [Abstract][Full Text] [Related]
8. Manual erythroexchange for chronic transfusion therapy in patients with sickle cell syndromes unresponsive to hydroxyurea: a long-term follow-up.
Carrara P; Balocco M; Pinto V; Olcese F; Soldà A; Strada P; Forni GL
Am J Hematol; 2010 Dec; 85(12):974. PubMed ID: 21108330
[No Abstract] [Full Text] [Related]
9. Transfusion of sickle cells may be a therapeutic option for patients suffering metastatic disease.
Goldberg JS
Med Hypotheses; 2010 Apr; 74(4):629-30. PubMed ID: 20022432
[TBL] [Abstract][Full Text] [Related]
10. Regular automated red cell exchange transfusion in the management of pulmonary hypertension in sickle cell disease.
Tsitsikas DA; Seligman H; Sirigireddy B; Odeh L; Nzouakou R; Amos RJ
Br J Haematol; 2014 Dec; 167(5):707-10. PubMed ID: 25041505
[No Abstract] [Full Text] [Related]
11. Transfusion protocols for patients with sickle cell disease: working toward consensus?
Meny GM
Immunohematology; 2012; 28(1):1-2. PubMed ID: 22822518
[No Abstract] [Full Text] [Related]
12. Indications for red cell transfusion in sickle cell disease.
Ohene-Frempong K
Semin Hematol; 2001 Jan; 38(1 Suppl 1):5-13. PubMed ID: 11206961
[TBL] [Abstract][Full Text] [Related]
13. Should we still be focused on red cell hemoglobin F as the principal explanation for the salutary effect of hydroxyurea in sickle cell disease?
Segel GB; Simon W; Lichtman MA
Pediatr Blood Cancer; 2011 Jul; 57(1):8-9. PubMed ID: 21480473
[No Abstract] [Full Text] [Related]
14. [Transfusion and sickle cell disease: axes of transfusion safety optimization].
Noizat-Pirenne F
Transfus Clin Biol; 2014 May; 21(2):77-84. PubMed ID: 24811565
[TBL] [Abstract][Full Text] [Related]
15. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
16. Management of sickle cell disease: recent advances and controversies.
Castro O
Br J Haematol; 1999 Oct; 107(1):2-11. PubMed ID: 10520020
[No Abstract] [Full Text] [Related]
17. Evidence gaps in the management of sickle cell disease: A summary of needed research.
Savage WJ; Buchanan GR; Yawn BP; Afenyi-Annan AN; Ballas SK; Goldsmith JC; Hassell KL; James AH; John-Sowah J; Jordan L; Lottenberg R; Murad MH; Ortiz E; Tanabe PJ; Ware RE; Lanzkron SM
Am J Hematol; 2015 Apr; 90(4):273-5. PubMed ID: 25639238
[No Abstract] [Full Text] [Related]
18. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.
Lebensburger J; Johnson SM; Askenazi DJ; Rozario NL; Howard TH; Hilliard LM
Am J Hematol; 2011 May; 86(5):430-2. PubMed ID: 21523807
[TBL] [Abstract][Full Text] [Related]
19. Erythrocytapheresis in pregnant patients with sickle hemoglobinopathies.
Morrison JC; Douvas SG; Martin JN; Blake PG; Wiser WL; Durham MC; Morrison FS
Am J Obstet Gynecol; 1984 Aug; 149(8):912-4. PubMed ID: 6465264
[No Abstract] [Full Text] [Related]
20. Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia.
Brousse V; Gandhi S; de Montalembert M; Height S; Dick MC; O'Driscoll S; Abihsera G; Rees DC
Br J Haematol; 2013 Jan; 160(2):259-61. PubMed ID: 23116405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
